(All times are in Central Standard Time)
|
|
|
Ancillary Educational Events
(In-person only, not available for online or virtual viewing)
|
7:45 – 9:15 am |
CBCS - Chinese Breast Cancer Society
Location: Room 301ABC
|
8:00 – 9:30 am |
Lilly Advocate Program
Location: Room 220ABC
|
9:30 – 10:45 am |
ABC Global Alliance Ten Year Breast Cancer Report
Location: Room 221ABC
|
9:30 – 11:00 am |
St. Galan Updates
Location: Room 301ABC
|
|
SABCS Program Begins
|
11:00 am – 12:30 pm |
Trainee Workshop: Enhanced Research and Community Impact
Location: 221ABC
|
11:00 am – 12:30 pm |
Special Session 1 - Open Bar and All you Can Eat? The Impact of Lifestyle in Breast Cancer Risk and Recurrence
Location: Stars at Night 1 & 2
Moderator: Seema Khan, MD, MS, Northwestern University Feinberg School of Medicine, Chicago
11:00 AM - 11:25 AM - Topic 1: Alcohol, genetics of alcohol metabolism and breast cancer risk
- Julia Palmer, ScD, Boston University, Boston
11:25 AM - 11:55 AM - Topic 2: Effects of alcohol consumption and cessation on breast cancer risk
- Mary Beth Terry, PhD, Columbia University, New York
11:55 AM - 12:15 PM - Topic 3: Obesity and Breast Cancer- the molecular link
- Kristy Brown, PhD, University of Kansas Medical Center, Kansas City, Kansas
Patient Advocate: Stacey Tinianov, MPH, BCPA, Advocates for Collaborative Education, Santa Cruz, California
12:15 PM - 12:30 PM Panel Q&A
|
11:00 am – 12:30 pm |
Special Session 2: Lobular Breast Cancer Updates
Location: Stars at Night 3 & 4
Moderator: Steffi Oesterreich, PhD, UPMC Hillman Cancer Center, Pittsburgh & Marleen Kok, MD, PhD, Netherlands Cancer Institute, Amsterdam
11:10 AM - 11:25 Topic 1: Current updates on diagnostic criteria and classification of special subtypes
- Anne Vincent-Salomon, PhD, Institut Curie, Paris
11:25 AM - 11:40 AM Topic 2: Novel biomarkers with clinical implications
- Christos Sotiriou, MD, PhD, Institut Jules Bordet, Anderlecht, Belgium
11:40 AM - 11:55 AM Topic 3: Controversies in clinical decision making – is there still a role for chemotherapy?
- Otto Metzger, MD, Dana-Farber Cancer Institute, Boston
11:55 AM - 12:10 PM Topic 4: LC-specific trials: lessons learned and future designs
- Philipe Aftimos, MD, Insitut Jules Bordet, Anderlecht, Belgium
12:10 PM - 12: 30 PM Panel discussion
Patient Advocate: Flora Migyanka, BA, Dynami Foundation
|
11:00 am – 12:30 pm |
Special Session 3: Breast Cancer in Young Women: Biology, Treatment, and Ethics
Location: TBD
Moderator: Ann Partridge, MD, MPH, Dana-Farber Cancer Institute, Boston
11:00 AM - 11:30 AM Topic 1: Epidemiology and Biology of Young Onset Breast Cancer
- Virginia Borges, MD, UCHealth Diane O’Connor Thompson Breast Center – Anschutz Medical Campus, Aurora, Colorado
11:30 AM - 12:00 PM Topic 2: Special Management Considerations for Young Patients with Breast Cancer
- Yara Abdou, MD, MSCR, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
12:00 PM - 12:30 PM Topic 3: Ethical Issues in the Care of Young Patients with Breast Cancer
- Lisa Campo-Engelstein, PhD, University of Texas Medical Branch, Galveston, Texas
|
12:45 – 2:15 pm |
Translational Workshop 1: Spatial Omics for Prediction, Prognostication, and Mechanistic Insights
Location: Stars at Night 1-2
Moderator: Leif Ellisen, MD, PhD, Harvard University, Cambridge, Massachusetts
12:45 PM -1:10 PM Topic 1: Proteomics
- Sandro Santagata, MD, PhD, Harvard Medical School, Cambridge, Massachusetts
1:10 PM - 1:35 PM Topic 2: Metabolomics+
- Ralph Deberardinis, MD, PhD, UT Southwestern, Dallas
1:35 PM - 2:00 PM Topic 3: Gylcocomics
2:00 PM - 2:15 PM Panel discussion
Patient advocate: Jane Perlmutter, PhD
|
12:45 – 2:15 pm |
Translational Workshop 2: Liquid Biopsy in Breast Cancer, Bridging Technology and Clinical Practice
Location: Stars at Night 3-4
Moderator: Pedram Razavi, MD, PhD, Memorial Sloan Kettering Cancer Center, New York
12:45 PM - 1:10 PM Topic 1: Emerging technologies in liquid biopsy
- Maximilian Diehn, MD, PhD, Stanford University, Stanford, California
1:10 PM - 1:35 PM Topic 2: Expanding clinical application of liquid biopsy in breast cancer
- Pedram Razavi, MD, PhD, Memorial Sloan Kettering Cancer Center, New York
1:35 PM - 2:00 PM Topic 3: Utilizing liquid biopsy for detection and monitoring CNS metastases
-
Alexandra Miller, MD, PhD, NYU Langone Health Perlmutter Cancer Center, New York
2:00 PM - 2:15 PM Panel discussion
Patient advocate: Michelle Tregear, National Breast Cancer Coalition
|
12:45 – 2:15 pm |
Clinical Workshop 1: Risk Assessment and Management in Young Women
Location: Hemisfair Ballroom 1-2
12:45 PM - 12:55 PM Moderator: Sonya Reid, MD, MPH, Vanderbilt-Ingram Cancer Center, Nashville
12:55 PM - 1:10 PM Topic 1: Surveillance strategies for young women – when and how often?
- Allison Kurian, MD, M.Sc, Stanford Medicine, Stanford, California
1:10 PM - 1:25 PM Topic 2: Novel imaging strategies for young women – looking to the future
- Emily Conant, MD, University of Pennsylvania Perelman School of Medicine, Philadelphia
1:25 PM - 1:40 PM Topic 3: Should management of atypia in young women differ?
- Laura K. Harper, Mayo Clinic, Phoenix, Arizona
1:40 PM - 1:55 PM Topic 4: Considerations for Prevention – balancing fertility and risk
- Seema Kahn, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
1:55 PM - 2:15 PM Panel discussion
Patient Advocate: Vernal Branch, Independent Research Patient Advocatie, Richmond, Virginia
|
12:45 – 2:15 pm |
Careeer Development: Compassionate Leadership Workshop
Location: 221ABC
Speaker: Anne Welsh
|
2:30 – 4:15 pm |
Educational Session 1: After CDK4/6 Inhibitors: Advancing Treatment for HR+HER2-negative Metastatic Breast Cancer
Location: Stars at night 1-2
Moderator: Antoinette Tan, MD, MHS, Wake Forest University School of Medicine, Charlotte, North Carolina
2:30 PM - 3:00 PM Topic 1: Treatment Strategies after CDK4/6 Inhibitor Progression
- Mafalda Oliveira, MD, PhD, Vall d'Hebron Hospital, Barcelona
3:00 PM - 3:30 PM Topic 2: Next Generation Endocrine Agents
- Erica Mayer, MD, MPH, Dana-Farber Cancer Institute, Boston
3:30 PM - 4:00 PM Topic 3: Emerging Agents to Overcome CDK4/6 Inhibitor Resistance
- Shom Goel, PhD, FRACP, Peter MacCallum Cancer Centre, Melbourne, Australia
4:00 PM - 4:15 PM Panel Q&A
Patient Advocate: Abigail Johnston, SurvivingBreastCancer.org, Orlando, Florida
|
2:30 – 4:15 pm |
Educational Session 2: Dormancy and Re-activation of Breast Cancer Cells at Distant Metastatic Sites
Location: 221 ABC
Moderator: Heide Ford, PhD, University of Colorado School of Medicine, Denver
2:30 PM - 3:00 PM - Topic 1: Viral reactivation of dormant breast cancer
- Mercedes Rincon, PhD, University of Colorado School of Medicine, Aurora, Colorado
3:00 PM - 3:30 PM Topic 2: Role of alveolar macrophages in dormancy
- Xue-Yan He, PhD, Washington University in St. Louis
3:30 PM - 4:00 PM Topic 3: In vivo mechanisms regulating cellular dormancy and tumor recurrence
- Lewis Chodosh, PhD, University of Pennsylvania Perelman School of Medicine, Philadelphia
4:00 PM - 4:15 PM Panel Discussion
Patient Advocate: Lynda Weatherby, Metastatic Breast Cancer Alliance, Seattle
|
2:30 – 4:15 pm |
Educational Session 3: Refining Local Therapy in Multi-disciplinary Care
Location: Stars at Night 3-4
Moderator: Jonathan Strauss, MD, MBA, Roberts H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
2:30 PM - 3:00 PM Topic 1: Repeat Breast Conservation with reirradiation – what’s the data and how do we do it?
- Chelain Goodman, MD, PhD, MD Anderson Cancer Center, Houston
3:00 PM - 3:30 PM Topic 2: Should we irradiate the IM Nodes: Settling the Issue
- Birgitte Offersen, MD, Aarhus University Department of Oncology, Aarhus, Denmark
3:30 PM - 4:00 PM Topic 3: The Truth About Radiotherapy and Reconstruction
- Justin Broyles, MD, Brigham and Women’s Hospital, Boston
4:00 PM - 4:15 PM Panel Q&A
Patient Advocate: Judy Fitzgerald, Sisters4Prevention, Delray Beach, Florida
|
2:30 – 4:15 pm |
Educational Session 4: Balancing Act: Hormone Replacement Therapy in Breast Cancer Care
Location: Hemisfair Ballroom 1-2
Moderator: Tara Sanft, MD, Yale School of Medicine, New Haven, Connecticut
2:30 PM - 3:00 PM Topic 1: "HRT and Breast Cancer: How History Shaped Fear and What Comes Next" Re-examining past research, debunking myths, and guiding future recommendations
- Maryam Lustberg, MD, MPH, Yale School of Medicine, New Haven, Connecticut
3:00 PM - 3:30 PM Topic 2: "Navigating the Latest HRT Guidelines: What Leading Medical Societies Say" A comprehensive review of updated recommendations from major health organizations.
- Juliana Kling, MD, MPH, MACP, MSCP, Mayo Clinic, Phoenix
3:30 PM - 4:00 PM Topic 3: "HRT Across the Breast Cancer Spectrum: Risks, Benefits, and Considerations" Exploring HRT use in high-risk individuals, survivors, and different breast cancer subtypes.
- Lisa Larkin, MD, FACP, MSCP, Ms. Medicine/HERmedicine, Cincinnati, Ohio
4:00 PM - 4:15 PM Panel Q&A
Patient Advocate: Thelma Perry Brown, BS, Patient Research Advocate, Birmingham, Alabama
|
2:30 – 4:15 pm |
Educational Session 5: Best of AACR
Location: Hemisfair Ballroom 3
2:30 PM - 2:50 PM Topic 1: The Influence of ecDNA in Cancer
2:50 PM - 3:10 PM Topic 2: State of RAS Inhibitor Field
3:10 PM - 3:30 PM Topic 3: Decoding the archetypes and ecotypes of triple-negative breast cancer in responses to chemotherapy
3:30 PM - 3:50 PM Topic 4: An estrogen receptor signaling transcriptional program linked to immune evasion in human hormone receptor-positive breast cancer
3:50-4:10 Topic 5: Metastatic dissemination from the perspective of the cancer cell, its microenvironment, and the Host
|
4:30 – 5:30 pm |
Rapid Fire 1
Location: Stars at Night 1-2
|
5:15 – 5:45 pm |
Refreshment Break and Networking
Location: TBD
|
5:45 – 6:45 pm |
Rapid Fire 2
Location: Stars at Night 1-2
|